Acetaminophen Completed Phase 2 Trials for Transplantation, Autologous / Blood and Marrow Transplant (BMT) / Multiple Myeloma (MM) / Transplantation, Homologous Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT00899847Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
NCT01985126An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD